$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Combined oral contraceptive use is associated with both improvement and worsening of mood in the different phases of the treatment cycle-A double-blind, placebo-controlled randomized trial

Psychoneuroendocrinology, v.76, 2017년, pp.135 - 143  

Lundin, C. ,  Danielsson, K.G. ,  Bixo, M. ,  Moby, L. ,  Bengtsdotter, H. ,  Jawad, I. ,  Marions, L. ,  Brynhildsen, J. ,  Malmborg, A. ,  Lindh, I. ,  Sundstrom Poromaa, I.

Abstract AI-Helper 아이콘AI-Helper

Objective: Ever since the introduction of combined oral contraception (COC), one of the major reasons for discontinuing the pill use has been mood-related side effects. Moreover, women who discontinue the pill turn to less effective methods whereby the probability of an unintended conception increas...

주제어

참고문헌 (37)

  1. Psychoneuroendocrinology Ansseau 18 37 1993 10.1016/0306-4530(93)90053-N Oral contraceptives and the dexamethasone suppression test 

  2. Psychoneuroendocrinology Borgstrom 33 487 2008 10.1016/j.psyneuen.2008.01.007 Patients with adverse mood effects from combined oral contraceptives have lower levels of prepulse inhibition than healthy controls 

  3. Psychopharmacology (Berl) Braff 156 234 2001 10.1007/s002130100810 Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies 

  4. Psychoneuroendocrinology Bouma 34 884 2009 10.1016/j.psyneuen.2009.01.003 Adolescents' cortisol responses to awakening and social stress; effects of gender, menstrual phase and oral contraceptives. The TRAILS study 

  5. Am. J. Psychiatry Eisenlohr-Moul 2016 Toward the reliable diagnosis of DSM-5 premenstrual dysphoric disorder: the Carolina Premenstrual Assessment Scoring System (C-PASS) 

  6. Arch. Womens Ment. Health Endicott 9 41 2006 10.1007/s00737-005-0103-y Daily Record of Severity of Problems (DRSP): reliability and validity 

  7. Neuroscience Frokjaer 163 640 2009 10.1016/j.neuroscience.2009.06.052 Gender and the use of hormonal contraception in women are not associated with cerebral cortical 5-HT 2A receptor binding 

  8. Psychoneuroendocrinology Gingnell 38 1133 2013 10.1016/j.psyneuen.2012.11.006 Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill-a double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive 

  9. Biol. Psychiatry Graham 73 371 2013 10.1016/j.biopsych.2012.09.018 Blockade of estrogen by hormonal contraceptives impairs fear extinction in female rats and women 

  10. Contraception Graham 52 363 1995 10.1016/0010-7824(95)00226-X The effects of steroidal contraceptives on the well-being and sexuality of women: a double-blind, placebo-controlled, two-centre study of combined and progestogen-only methods 

  11. Am. J. Obstet. Gynecol. Joffe 189 1523 2003 10.1016/S0002-9378(03)00927-X Impact of oral contraceptive pill use on premenstrual mood: predictors of improvement and deterioration 

  12. Psychoneuroendocrinology Kirschbaum 20 509 1995 10.1016/0306-4530(94)00078-O Preliminary evidence for reduced cortisol responsivity to psychological stress in women using oral contraceptive medication 

  13. Psychopharmacology (Berl) Kuhlmann 183 65 2005 10.1007/s00213-005-0143-z Cortisol and memory retrieval in women: influence of menstrual cycle and oral contraceptives 

  14. Aust. N. Z. J. Obstet. Gynaecol. Leeton 18 194 1978 10.1111/j.1479-828X.1978.tb00048.x The effects on sexual response and mood after sterilization of women taking long-term oral contraception: results of a double-blind cross-over study 

  15. Contraception Lindh 80 163 2009 10.1016/j.contraception.2009.01.019 Contraceptive use and pregnancy outcome in three generations of Swedish female teenagers from the same urban population 

  16. Cochrane Database Syst. Rev. Lopez 2 CD006586 2012 Oral contraceptives containing drospirenone for premenstrual syndrome 

  17. J. Psychosom. Res. Maes 36 191 1992 10.1016/0022-3999(92)90028-Z Disturbances in dexamethasone suppression test and lower availability of L-tryptophan and tyrosine in early puerperium and in women under contraceptive therapy 

  18. Eur. J. Contracept. Reprod. Health Care Mansour 16 430 2011 10.3109/13625187.2011.614029 Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17beta-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen 

  19. Soc. Cogn. Affect. Neurosci. Mareckova 9 191 2014 10.1093/scan/nss128 Hormonal contraceptives, menstrual cycle and brain response to faces 

  20. Neurobiol. Learn Mem. Nielsen 96 378 2011 10.1016/j.nlm.2011.06.013 Hormonal contraception usage is associated with altered memory for an emotional story 

  21. Biol. Psychol. Nielsen 92 257 2013 10.1016/j.biopsycho.2012.10.007 Hormonal contraception use alters stress responses and emotional memory 

  22. Contraception O’Connell 75 299 2007 10.1016/j.contraception.2006.09.008 Oral contraceptives: side effects and depression in adolescent girls 

  23. Fertil. Steril. Paoletti 81 645 2004 10.1016/j.fertnstert.2003.08.030 Psychological effect of the oral contraceptive formulation containing 3 mg of drospirenone plus 30 microg of ethinyl estradio 

  24. Contraception Pearlstein 72 414 2005 10.1016/j.contraception.2005.08.021 Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation 

  25. Soc. Cogn. Affect. Neurosci. Petersen 10 1266 2015 10.1093/scan/nsv010 Amygdala reactivity to negative stimuli is influenced by oral contraceptive use 

  26. Acta Obstet. Gynecol. Scand. Poromaa 91 420 2012 10.1111/j.1600-0412.2011.01333.x Adverse mood symptoms with oral contraceptives 

  27. Pharmacol. Biochem. Behav. Rapkin 84 628 2006 10.1016/j.pbb.2006.06.008 Oral contraceptives and neuroactive steroids 

  28. Contraception Segebladh 79 50 2009 10.1016/j.contraception.2008.08.001 Prevalence of psychiatric disorders and premenstrual dysphoric symptoms in patients with experience of adverse mood during treatment with combined oral contraceptives 

  29. J. Clin. Psychiatry Sheehan 59 Suppl. 20 22 1998 The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 

  30. JAMA Psychiatry Skovlund 73 1154 2016 10.1001/jamapsychiatry.2016.2387 Association of hormonal contraception with depression 

  31. Drugs Aging Soares 30 677 2013 10.1007/s40266-013-0100-1 Depression in peri- and postmenopausal women: prevalence, pathophysiology and pharmacological management 

  32. Fertil. Steril. Sullivan 72 115 1999 10.1016/S0015-0282(99)00205-8 Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activity 

  33. Front. Neurosci. Sundstrom Poromaa 8 380 2014 Menstrual cycle influence on cognitive function and emotion processing-from a reproductive perspective 

  34. Br. J. Psychiatry Vessey 146 45 1985 10.1192/bjp.146.1.45 Oral contraception and serious psychiatric illness: absence of an association 

  35. Psychiatry Res. Weizman 23 23 1988 10.1016/0165-1781(88)90031-5 Up-regulatory effect of triphasic oral contraceptive on platelet 3H-imipramine binding sites 

  36. Eur. J. Contracept. Reprod. Health Care Witjes 1 2015 Comparative analysis of the effects of nomegestrol acetate /17 beta-estradiol and drospirenone/ethinylestradiol on premenstrual and menstrual symptoms and dysmenorrhea 

  37. Obstet. Gynecol. Yonkers 106 492 2005 10.1097/01.AOG.0000175834.77215.2e Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder 

관련 콘텐츠

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트